Literature DB >> 28986034

Update on the epidemiology of rotavirus in the Middle East and North Africa.

Hassan Zaraket1, Rana Charide2, Khalil Kreidieh3, Ghassan Dbaibo4, Nada M Melhem5.   

Abstract

Rotavirus (RV) is the leading cause of severe acute gastroenteritis (AGE) worldwide. Consequently, we conducted a systematic literature review on articles studying RV in the 25 countries of the MENA region during the past 15years (2000-2015). The methods and reporting were set according to the 2015 preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) and based on the elements from the international prospective register of systematic reviews (PROSPERO). Our literature search identified 169 studies meeting our predefined inclusion criteria. Studies reporting on RV were conducted in 19 out of the 24 countries of the MENA region. The largest number of studies was reported in Turkey (n=32), Iran (n=31), Saudi Arabia (n=19) and Egypt (n=17). The majority of studies reporting on RV gastroenteritis rates were clinical observational studies. In 115 studies out of 169, RV was reported among in-patients whereas 35 studies reported RV among outpatients. The predominantly reported RV genotype in the region was G1[P8] followed by G2[P4] and G9[P8]. The majority of studies (n=108) were conducted among children less than 5years of age whereas the remaining studies reported on AGE among other age groups and rarely adults. In MENA countries, RV infection was reported all year round with peaks described in cold as well as hot months. This systematic review provides a current update on the epidemiology of RV-associated gastroenteritis in countries of the MENA region and draws attention to the major gaps existing in the continuous monitoring of RV.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute gastroenteritis; Genotype; Middle East and North Africa; Rotavirus; Seasonality

Mesh:

Year:  2017        PMID: 28986034     DOI: 10.1016/j.vaccine.2017.09.067

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  2 in total

1.  Evaluation of a commercial latex agglutination test for detecting rotavirus A and human adenovirus in children's stool specimens.

Authors:  Wenqing Xiang; Zhaoyang Peng; Jialu Xu; Hongqiang Shen; Wei Li
Journal:  J Clin Lab Anal       Date:  2020-01-13       Impact factor: 2.352

2.  Introduction of rotavirus vaccination in Palestine: An evaluation of the costs, impact, and cost-effectiveness of ROTARIX and ROTAVAC.

Authors:  Frédéric Debellut; Samer Jaber; Yaser Bouzya; Jehad Sabbah; Mustafa Barham; Fakhr Abu-Awwad; Diaa Hjaija; Assad Ramlawi; Clint Pecenka; Andrew Clark; Mercy Mvundura
Journal:  PLoS One       Date:  2020-02-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.